pandem
global
emerg
seek
new
therapeut
molecular
dynam
structurerguid
drug
discoveri
abet
propos
arbidol
potenti
antivir
drug
infect
arbidol
imped
trimer
spike
glycoprotein
inhibit
host
cell
adhes
bind
mode
arbidol
similar
hemagglutinin
influenza
viru
spike
glycoprotein
key
residu
involv
arbidol
bind
guid
develop
new
therapeut
pandem
urgent
global
public
health
emerg
warrant
investig
studi
bonafid
antivir
combat
report
drug
target
mechan
action
potenti
antivir
drug
arbidol
infect
structur
molecular
dynam
studi
show
arbidol
target
spike
glycoprotein
imped
trimer
spike
glycoprotein
key
host
cell
adhes
hijack
thu
place
arbidol
potenti
drug
repurpos
studi
also
abet
develop
new
therapeut
diseas
base
arbidol
bind
mode
use
structureguid
drug
design
current
pandem
potenti
lethal
novel
coronaviru
name
caus
major
impact
million
peopl
health
global
economi
http
date
death
nearli
two
million
confirm
posit
case
report
global
make
urgent
public
health
concern
along
side
use
use
neutral
antibodi
target
spike
glycoprotein
involv
host
cell
adhes
sever
antivir
drug
drug
hydroxychloroquin
also
evalu
repurpos
possibl
treatment
differ
class
antivir
evalu
includ
protein
inhibitor
ribavirin
lopinavirritonavir
rna
synthesi
inhibitor
remdesivir
tenofovir
disoproxil
fumaratetdf
neuraminidas
inhibitor
tamiflu
peramivir
small
molecul
drug
target
abil
interact
host
cell
inhibitor
howev
potenti
drug
target
mechan
sever
candid
drug
remain
elus
warrant
structur
biophys
studi
unravel
potenti
antivir
drug
bind
impact
among
clinic
advanc
sever
random
drug
trail
arbidol
umifenovir
fig
also
screen
howev
drug
target
viral
protein
mechan
action
arbidol
elus
essenti
understand
drug
action
mechan
develop
better
therapeut
consid
current
public
health
crisi
aim
unravel
potenti
drug
target
molecular
interact
address
mechan
action
arbidol
foremost
interest
us
know
arbidol
known
drug
influenza
bind
haemagglutinin
ha
protein
rais
intrigu
question
sequenc
structur
similar
spike
glycoprotein
influenza
viru
ha
protein
could
result
posit
drug
effect
compar
protein
sequenc
analysi
show
short
region
spike
glycoprotein
trimer
domain
resembl
ha
fig
outer
membran
spike
glycosyl
protein
essenti
host
cell
adhes
via
human
receptor
trimer
imper
host
membran
fusion
rais
intrigu
question
whether
arbidol
could
also
bind
similar
way
ha
spike
glycoprotein
find
potenti
arbidol
antivir
drug
bind
target
structur
studi
unravel
mechan
interact
great
implic
essenti
current
global
public
health
emerg
could
open
arena
develop
new
potenti
therapeut
end
perform
molecular
dynam
structureguid
drug
bind
analysi
screen
arbidol
bind
site
spike
glycoprotein
though
two
independ
server
http
haddockscienceuunl
ii
swissdock
http
swissdockchdock
reliabl
use
spike
glycoprotein
trimer
pdb
server
predict
consist
provid
six
possibl
posit
arbidol
could
potenti
interact
spike
glycoprotein
fig
among
obtain
six
cluster
arbidol
bind
site
notic
singl
fals
posit
singl
true
site
four
unimportantsurfac
bind
region
cluster
assess
corrobor
base
solvent
access
surfac
area
sasa
cscore
confid
score
zscore
clash
score
bind
locat
expos
residu
spike
glycoprotein
refin
complet
use
coot
wwwmrcimbcamuk
ensur
appropri
dock
clash
side
chain
residu
bind
free
energi
taken
consider
select
best
possibl
dock
site
final
model
aribidol
dock
homotrim
structur
spike
glycoprotein
fig
visualis
pymol
unravel
arbidol
bind
mode
mechan
action
first
look
possibl
amino
acid
residu
spike
glycoprotein
involv
establish
interact
arbidol
found
trimer
domain
make
interact
arbidol
either
via
van
der
waal
forc
hydrogen
bond
fig
fig
specif
arbidol
sandwich
trimer
helic
two
protom
chain
chain
b
fig
total
buri
interfac
three
arbidol
bind
region
arbidol
calcul
pisa
server
http
wwwebiacukpdbepisa
next
look
arbidol
interact
ha
protein
pdb
interestingli
notic
arbidol
interact
influenza
ha
protein
also
mediat
via
arg
ly
leu
glu
key
interact
residu
fig
furthermor
arbidol
sandwich
two
trimer
helic
two
protom
chain
b
fig
furthermor
found
posit
ha
bind
residu
similar
spike
glycoprotein
residu
furthermor
compar
exact
structur
similar
trimer
domain
involv
abridol
bind
superimpos
arbidol
bind
region
superimpos
rmsd
atom
also
suggest
possibl
structur
similar
drug
bind
region
spike
glycoprotein
influenza
viru
accentu
influenza
viru
drug
could
potenti
drug
infect
sequenc
structur
similar
bind
site
arbidol
solv
simul
seem
promis
suggest
arbidol
efficaci
combat
base
molecular
dynam
structur
studi
corrobor
spike
glycoprotein
drug
target
arbidol
incit
drug
bind
mode
key
interact
residu
mechan
arbidol
effect
block
imped
trimer
spike
glycoprotein
essenti
cell
adher
entri
block
trimer
spike
glycoprotein
also
lead
format
nake
unmatur
viru
least
infecti
although
studi
signific
implic
repurpos
know
drug
target
understand
mechan
viral
inhibit
efficaci
safeti
arbidol
still
requir
clinic
investig
current
drug
option
focus
inhibitor
viral
rna
polymeras
potenti
drug
imped
viral
spike
protein
trimer
also
equal
essenti
combin
drug
profound
effect
combat
viral
infect
studi
also
accentur
develop
new
therapeut
base
arbidol
use
structureguid
drug
design
